Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Jul;26(1):39–41. doi: 10.1128/aac.26.1.39

Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.

F Soriano, M C Ponte
PMCID: PMC179913  PMID: 6089653

Abstract

The activities of aztreonam and cefotaxime against one Escherichia coli strain and three Bacteroides strains have been studied by using pure and mixed cultures of aerobic and anaerobic bacteria. A fixed concentration (8 micrograms/ml) of cefotaxime or aztreonam killed E. coli that was exposed in pure culture, but the pressure of Bacteroides spp. in the same system deteriorated cefotaxime, allowing the full growth of E. coli after 24 h. On the other hand, the presence of Bacteroides spp. produced less deterioration of aztreonam, which reduced the initial E. coli inoculum. This observation could be useful in clinical practice when treating mixed aerobic and anaerobic infections.

Full text

PDF
39

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Drasar F. A., Farrell W., Howard A. J., Hince C., Leung T., Williams J. D. Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J Antimicrob Chemother. 1978 Sep;4(5):445–450. doi: 10.1093/jac/4.5.445. [DOI] [PubMed] [Google Scholar]
  2. Jacobus N. V., Ferreira M. C., Barza M. In vitro activity of azthreonam, a monobactam antibiotic. Antimicrob Agents Chemother. 1982 Nov;22(5):832–838. doi: 10.1128/aac.22.5.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Livermore D. M., Williams J. D. In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):29–37. doi: 10.1093/jac/8.suppl_e.29. [DOI] [PubMed] [Google Scholar]
  4. Onderdonk A. B., Bartlett J. G., Louie T., Sullivan-Seigler N., Gorbach S. L. Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976 Jan;13(1):22–26. doi: 10.1128/iai.13.1.22-26.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Phillips I., King A., Shannon K., Warren C. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):103–110. doi: 10.1093/jac/8.suppl_e.103. [DOI] [PubMed] [Google Scholar]
  6. Soriano F., Ponte C., Santamaría M. Activity of cefotaxime and metronidazole against bacteroides and Escherichia coli alone and in mixed culture. J Antimicrob Chemother. 1983 Jul;12(1):89–92. doi: 10.1093/jac/12.1.89. [DOI] [PubMed] [Google Scholar]
  7. Soriano F., Ponte M. C., Gaspar M. C. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole. J Clin Pathol. 1982 Oct;35(10):1150–1152. doi: 10.1136/jcp.35.10.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H., Wells J. S. Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):1–16. doi: 10.1093/jac/8.suppl_e.1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES